Build an HIV rapid start clinic: same-day ART, baseline labs, linkage to care, adherence…
- User
Build an HIV rapid start clinic: same-day ART, baseline labs, linkage to care, adherence supports, and viral suppression dashboard.
- Assistant
HIV Rapid Start Clinic Blueprint: "RapidShield Clinic"
Mission: Deliver same-day HIV treatment initiation (Rapid ART) to newly diagnosed individuals, ensuring immediate viral suppression, seamless linkage to long-term care, robust adherence support, and real-time population-level monitoring via a viral suppression dashboard. Goal: Achieve >90% viral suppression at 6 months, per WHO/CDC rapid start guidelines.
Target Population: Adults/adolescents with new HIV diagnoses (acute/chronic), regardless of CD4 count, viral load, or comorbidities. Capacity: 20-50 patients/week initially.
Location/Setup: Urban clinic (1,000-2,000 sq ft) with private exam rooms, phlebotomy station, counseling spaces, pharmacy dispensary, and telehealth booths. Integrate with existing HIV testing sites (e.g., STD clinics, ERs).
1. Operational Patient Flow (Same-Day ART Protocol)
Arrival (Dx confirmed) → Rapid Assessment (15 min) → Baseline Labs (STAT) → ART Initiation (30 min) → Adherence Counseling (20 min) → Linkage Scheduling → Exit with 30-day Rx + Supports Total visit: <2 hours-
Rapid Assessment:
- History/physical: Symptoms, comorbidities (TB, hep C, STIs, mental health), pregnancy status.
- HIV confirmation: 4th-gen Ag/Ab + viral load (if not done).
- INSTI-based regimen: Bictegravir/TAF/FTC (Biktarvy) or DTG + TAF/FTC for most; adjust for resistance/pregnancy.
- Contraindications: None absolute for rapid start; defer only CrCl <30 mL/min (use alternatives).
-
Baseline Labs (Point-of-Care + Send-Out):
Test Method Turnaround Purpose HIV VL POC (e.g., Xpert HIV-1 Qual) or lab <1 hr / 24-48 hr Confirm Dx, baseline CD4 POC (e.g., BD FACSPresto) <30 min Opportunistic infection risk Creatinine/eGFR POC chemistry analyzer <15 min Renal safety HBV/HCV POC serology <30 min Co-infection screen Pregnancy (women) Urine hCG Instant Regimen selection CMP, lipids, glucose, RPR Send-out 24-48 hr Baseline monitoring HLA-B*5701 (if ABC planned) Send-out 48 hr Hypersensitivity screen Equipment: Invest $50K in POC devices (e.g., GeneXpert, i-STAT).
2. Linkage to Care
- Immediate Scheduling: Auto-book follow-up within 7 days (lab results review, adherence check).
- Strategies:
- Patient navigator (peer specialist) assigns warm handoff to primary HIV provider.
- Text/APP reminders + transportation vouchers.
- Partnerships: Local Ryan White clinics, PrEP/PEP programs.
- Retention target: 90% at 3 months via ASSIST model (peer navigation).
3. Adherence Supports
- Tiered Interventions:
Level Tools Trigger Universal 30-day blister-packed Rx, pictorial instructions, 24/7 nurse hotline. All patients Enhanced Wisepill/smart caps for real-time adherence texting; weekly peer check-ins. New to care, MH issues Intensive Motivational interviewing, CBT for stigma/depression; MOUD for SUD. VL >200 at 1 mo or missed visits - Digital: Free app (e.g., custom "ShieldTrack") for med reminders, side-effect reporting, video counseling.
- Incentives: $20 gift cards for 90% adherence (tracked via pharmacy fills).
4. Viral Suppression Dashboard
Tech Stack: Build with Tableau/Power BI ($10K/yr) integrated to EHR (e.g., Epic/OpenEMR) + lab APIs. Hosted on secure cloud (HIPAA-compliant).
-
Key Metrics (Real-Time Views):
Metric Definition Target Alerts Suppression Rate % with VL <200 at 3/6/12 mo >90% <85% → Auto-notify navigators Linkage % with visit <30 days >90% No-show → Text cascade Adherence % 90-day fills / smart cap opens >85% <80% → Peer outreach Retention % with q3mo visits >85% Lapsed → Home visit Population Trends Heatmap by zip/demo N/A Outbreak signals -
Features:
- Role-based access: Clinicians (patient-level), admins (aggregate).
- Predictive analytics: ML model flags high-risk (e.g., young MSM, low SES).
- Export for grants (HRSA 2605/2606 funding).
Demo Mockup:
[Dashboard Screenshot Placeholder] - Gauge: 92% Suppression (Green) - Line Chart: VL trends by cohort - Patient List: "John D. - VL 150k, Adherence 70% → PRIORITY"Staffing (Core Team, 5 FTEs + Part-Time)
- Physician/NP (1): Oversees ART starts.
- RN/Phlebotomist (2): Labs, vitals, injections.
- Pharmacist (0.5): Dispensing, counseling.
- Peer Navigator/Social Worker (1): Linkage/adherence.
- Data Analyst (0.5 PT): Dashboard maintenance.
- Volunteers: Community health workers.
Budget (Year 1): $750K
Category Cost Staff $500K POC Labs/Equipment $100K Meds (340B pricing) $50K IT/Dashboard $50K Rent/Supplies $50K Implementation Roadmap (6 Months)
- Month 1: Secure funding (HRSA, CDC), site selection, IRB for QI.
- Month 2: Hire/train staff, procure POC gear, build EHR/dashboard.
- Month 3: Pilot with 10 patients; refine protocols.
- Month 4-6: Full launch, weekly QI meetings, scale via referrals.
- Ongoing: Monthly reports to stakeholders; expand to PrEP rapid start.
Evidence Base: Supported by BHIVA/CDC guidelines; studies (e.g., RDT trial) show 91% suppression at 48w vs. 78% standard care. Reduces transmission by 96%.
Next Steps: Customize for your location? Provide sample protocols/forms? Let's iterate! 🛡️
-
Other models, same or similar prompt
Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.